Eli Lilly has unveiled a $27bn investment in US manufacturing facilities as the pharmaceutical industry prepares for the threat of tariffs and mounts a charm offensive aimed at President Donald Trump’s new administration.
礼来(Eli Lilly)宣布对美国生产设施投资270亿美元。此际，制药业正准备应对关税威胁，并对美国总统唐纳德•特朗普(Donald Trump)的新政府发起魅力攻势。
您已阅读8%（306字），剩余92%（3614字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。